Tuesday, November 14, 2023
- 9:00AM-11:00AM
-
Abstract Number: 1834
Evaluation of Fibromyalgia, Clinical/Serologic Activity, and Patient Reported Outcomes in a Racially/Ethnically Diverse SLE Patient Cohort
(1827–1839) Fibromyalgia & Other Clinical Pain Syndromes Poster- 9:00AM-11:00AM
-
Abstract Number: 1972
Evaluation of Myositis Autoantibodies as Predictors of Response to IVIG: Post-hoc Analysis of a Large Randomized, Double-Blind, Placebo-Controlled Phase III Trial
(1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III- 9:00AM-11:00AM
-
Abstract Number: 2106
Evaluation of the Construct of Constitutional Stiffness (CS) in Anti-CCP-Antibody-Positive Rheumatoid Arthritis (ACPA+RA) and Controls
(2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III- 9:00AM-11:00AM
-
Abstract Number: 2412
Evaluation of the Pretest Probability Score, Ultrasound and Biopsy on GCA Diagnose: Data from Real Clinical Practice
(2387–2424) Vasculitis – Non-ANCA-Associated & Related Disorders Poster III- 9:00AM-11:00AM
-
Abstract Number: 1860
Evaluation of the Receipt of Adequate Pharmacological and Psychological Treatment for Incident Depression and Anxiety in Individuals Living with Inflammatory Arthritis
(1840–1861) Health Services Research Poster III- 9:00AM-11:00AM
-
Abstract Number: 2183
Evolution of Lymphoma Predictors in Primary Sjogren’s Syndrome by Data Driven Analysis in Harmonized Patients
(2177–2194) Sjögren’s Syndrome – Basic & Clinical Science Poster II- 9:00AM-11:00AM
-
Abstract Number: 1859
Examining Hydroxychloroquine Prescribing and SLE Damage in a Statewide Lupus Cohort
(1840–1861) Health Services Research Poster III- 9:00AM-11:00AM
-
Abstract Number: 2124
Expansion of Atypical B Cells Accompanies Rheumatoid Arthritis-like Immune Dysregulation in ACPA+ At-risk Individuals
(2095–2140) RA – Diagnosis, Manifestations, and Outcomes Poster III- 9:00AM-11:00AM
-
Abstract Number: 1790
Expansion of CD8+ TCRVβ9+ T Cells in the Peripheral Blood of HLA-B27+ Patients with Axial Spondyloarthritis
(1776–1795) Spondyloarthritis Including Psoriatic Arthritis – Basic Science Poster- 9:00AM-11:00AM
-
Abstract Number: 2267
Explainable Machine Learning to Predict Hospitalized Infection in Patients with Systemic Lupus Erythematosus
(2257–2325) SLE – Diagnosis, Manifestations, & Outcomes Poster III- 9:00AM-11:00AM
-
Abstract Number: 2157
Exploratory Analysis of the Mechanisms of Action of the Potential Analgesic Effect of Tofacitinib and Adalimumab over Placebo in Patients with Rheumatoid Arthritis: Results of a Mediation Modeling Analysis
(2141–2176) RA – Treatments Poster III- 9:00AM-11:00AM
-
Abstract Number: 1740
Exploring Disease-Associated DNA Methylome Alterations in Rheumatoid Arthritis: Potential Diagnostic and Prognostic Biomarkers
(1734–1775) RA – Etiology and Pathogenesis Poster- 9:00AM-11:00AM
-
Abstract Number: 2020
Exploring Experiences and Perspectives of Canadian Patients with Lupus Nephritis Through Photovoice
(2019–2038) Patient Outcomes, Preferences, & Attitudes Poster III- 9:00AM-11:00AM
-
Abstract Number: 2218
Exploring Metabolite Markers Associated with Treatment Response of Biologic Disease Modifying Antirheumatic Drugs in Psoriatic Arthritis Patients